Abstract:Tandem C–N
bond formation for the oxidative annulation of
indolines with aziridines is accomplished employing the combination
of DDQ and NaOCl at ambient conditions. Optically active aziridine
can be coupled with high enantiomeric purity (>99% ee). The substrate
scope, stereocontrol with the enantioenriched substrate, and scale-up
are the important practical advantages.
“…Based on the above experimental results and previous literature reports, [13] the following possible mechanism is proposed (Scheme 4). First, Pd(II) is coordinated with the oxygen atom of the acetyl group, and the carbon-hydrogen activation occurs with the ortho CÀ H bond of acetanilide to form palladium intermediate I with a six-membered ring.…”
Section: L)mentioning
confidence: 62%
“…In order to promote the CÀ H activation process, a series of additives were screened, [17] such as Sn(OTf) 2 , La(OTf) 3 , Fe(OTf) 3 and LiOTf. When LiOTf was used as the additive, the target product can be obtained with a yield of 73% (entries [11][12][13][14].…”
A palladium-catalyzed cross-coupling of an ortho-C(sp 2 ) atom of aromatic amines with aliphatic aziridines to construct the O-aminophenethylamine skeleton via CÀ H activation has been developed. The reaction proceeded under mild conditions with good substrate scope. The O-aminophenethylamine skeleton in drugs or bioactive compounds could be generated in one step in this report.
“…Based on the above experimental results and previous literature reports, [13] the following possible mechanism is proposed (Scheme 4). First, Pd(II) is coordinated with the oxygen atom of the acetyl group, and the carbon-hydrogen activation occurs with the ortho CÀ H bond of acetanilide to form palladium intermediate I with a six-membered ring.…”
Section: L)mentioning
confidence: 62%
“…In order to promote the CÀ H activation process, a series of additives were screened, [17] such as Sn(OTf) 2 , La(OTf) 3 , Fe(OTf) 3 and LiOTf. When LiOTf was used as the additive, the target product can be obtained with a yield of 73% (entries [11][12][13][14].…”
A palladium-catalyzed cross-coupling of an ortho-C(sp 2 ) atom of aromatic amines with aliphatic aziridines to construct the O-aminophenethylamine skeleton via CÀ H activation has been developed. The reaction proceeded under mild conditions with good substrate scope. The O-aminophenethylamine skeleton in drugs or bioactive compounds could be generated in one step in this report.
“…Tunge et al . developed another efficient route using inexpensive Brønsted acid catalysts to promote a redox amination process, which could efficiently realize the multistep coupling of anilines and indolines to synthesize N -aryl-1-amino indoles (Scheme b) . Inspiring by these ideas and our previous finding about o -nitrobenzyl alcohols, herein, we disclosed a protocol which realize the construction of N -aryl-1-amino indoles in one-pot by a redox coupling process (Scheme c).…”
A novel method to synthesize N-aryl-1-amino indoles
was established by the photoinduced N–N coupling reaction.
This protocol is by treatment of o-nitrobenzyl alcohols
and indolines in the presence of TEAI and acetic acid with a 24 W
ultraviolet (UV) light-emitting diode (LED) (385–405 nm) irradiation.
The products bearing an aldehyde group can be further transformed
to fluorescent probes based on Rhodamine 6G derivative 11, which shows a high specificity and sensitivity for Fe3+.
Iron(II) catalyzed direct NÀ H/NÀ Me aziridination of olefins using O-arylsulfonyl hydroxylamines is described. This stereospecific, mild, economical, open-air, operationally simple, and environmentally benign procedure afforded the high yields of aziridines in a shorter reaction time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.